Ertugliflozin Lowers Uric Acid and Reduces Gout Risk in Type 2 Diabetes Patients with CVD, VERTIS CV Analysis Medha Baranwal24 Sept 2024 9:00 AM ISTCanada: Recent post hoc analyses from the VERTIS CV trial reveal promising results for ertugliflozin, a medication used to manage type 2 diabetes. The...
Study Reveals Genetic Connection Between Cardiovascular Disease and Psoriasis, Paving the Way for New Therapies Medha Baranwal24 Sept 2024 9:00 AM ISTUK: A recent Mendelian randomization (MR) study has uncovered significant evidence that genetic predictors of cardiovascular disease are associated...
Dulaglutide Offers Dual Benefits for Elderly: Improved Blood Sugar Control and Knee OA Pain Relief, Study Finds Medha Baranwal24 Sept 2024 8:00 AM ISTIndia: A recent study has shed light on the dual benefits of dulaglutide, a glucagon-like peptide-1 (GLP-1) receptor agonist, in managing both blood...
Longer Labor Duration During Second-Trimester Medication Abortions Raises Risk of Adverse Maternal Outcomes: Study Medha Baranwal23 Sept 2024 10:45 PM ISTUSA: Recent research has revealed that the length of labor during medication-induced abortions between 14 and 27 weeks of gestation is significantly...
Cognitive Decline Increases Risk of Natural Cause Mortality in Schizophrenia, New Study Reveals Medha Baranwal23 Sept 2024 8:00 PM ISTUSA: A recent prospective cohort study published in JAMA Network Open has identified lower cognitive functioning as a significant risk factor for...
Indian Study Points to Growing Antimicrobial Resistance in Critical Care, Calls for Immediate Action Medha Baranwal23 Sept 2024 10:00 AM ISTIndia: A recent review published online in Medical Journal Armed Forces India (MJAFI) highlights the alarming rise of antimicrobial resistance...
Enhancing Well-Being: Promising Strategy for CVD Prevention, UK Biobank Study Reveals Medha Baranwal23 Sept 2024 9:00 AM ISTChina: An analysis of the UK Biobank has revealed that individuals who report low levels of well-being face a heightened risk of cardiovascular...
GLP-1 Receptor Agonists Linked to Lower Risk of Cirrhosis Progression in Early-Stage Metabolic Liver Disease, Study Finds Medha Baranwal23 Sept 2024 8:00 AM ISTUSA: Recent findings from a cohort study have highlighted the potential benefits of GLP-1 receptor agonists (GLP-1 RAs) in managing patients with...
Temporary Uterine Artery Clamping Beneficial in Reducing Postpartum Hemorrhage During Cesarean Sections: Study Medha Baranwal22 Sept 2024 10:30 PM ISTSpain: A recent randomized controlled trial, published in BMC Pregnancy and Childbirth, has revealed that temporary clamping of the uterine arteries...
Half-Light Dose BF-200 ALA PDT Promising for Severe Actinic Keratosis, Study Finds Medha Baranwal22 Sept 2024 9:15 PM ISTSpain: Within the specialty of dermatology, a new study has shed light on the effectiveness of a novel photodynamic therapy (PDT) approach using...
Study Reveals High Rates of Orthostatic Intolerance in Lung Cancer Surgery Patients, Suggests Focus on Pain Management Medha Baranwal22 Sept 2024 9:00 PM ISTChina: A recent prospective observational study has revealed a significant prevalence of orthostatic intolerance (OI) in patients recovering from...
Subcutaneous Furosemide May Offer Effective Home-Based Treatment for Heart Failure, suggests new Pilot Study Medha Baranwal21 Sept 2024 9:00 AM ISTUSA: Results from the AT HOME-HF pilot study have shown that subcutaneous (SC) furosemide, an innovative method of diuretic therapy administration,...
